Enteric fever, primarily caused by Salmonella typhi or Salmonella paratyphi, presents significant challenges to modern healthcare, particularly in developing countries. Effective management requires comprehensive strategies that encompass prevention, timely diagnosis, and appropriate treatment.
Prevention remains the cornerstone of enteric fever management. This includes improving sanitation and access to clean drinking water, food safety measures, and vaccination. Typhoid conjugate vaccines (TCVs) have shown promising results, with WHO recommending their use in endemic areas.
Early and accurate diagnosis is pivotal. Conventional methods like blood culture remain the gold standard but suffer from low sensitivity. Newer diagnostic techniques, such as molecular methods and serological tests, offer improved sensitivity and specificity, albeit at a higher cost.
Treatment primarily involves antibiotic therapy. However, the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains necessitates careful antibiotic selection. Current guidelines recommend third-generation cephalosporins or fluoroquinolones for uncomplicated cases and carbapenems for severe or MDR/XDR cases. Patient monitoring and supportive care are also crucial.
Antimicrobial resistance (AMR) is a significant concern in enteric fever management. Strategies to combat AMR include surveillance for drug-resistant strains, antibiotic stewardship programs, and research into novel antimicrobials and alternative therapies.
In conclusion, effective management of enteric fever necessitates a comprehensive, multi-faceted approach. Preventive measures, improved diagnostics, appropriate treatment protocols, and strategies to address AMR are all integral components. As healthcare professionals, our role extends beyond treating individual patients to influencing public health policies and advocating for necessary resources to combat this global health threat.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation